Replimune Group, Inc. (REPL) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $1.0M. Most recent filing: Aug. 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 24, 2026 filed Aug. 20, 2026 | Astley-Sparke Philip Director | $0 | 50,000 | −4% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | Hill Emily Luisa Chief Financial Officer | −$132,176 | 9,256 | −4% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Patel Sushil Chief Executive Officer | −$510,253 | 39,341 | −5% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Hill Emily Luisa Chief Financial Officer | −$148,481 | 11,448 | −5% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Xynos Konstantinos Chief Medical Officer | −$148,468 | 11,447 | −5% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free